Latest Innovation News

Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.

Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.

Abacus Storage King reported a modest 1.1% increase in statutory profit for HY25, underpinned by resilient operating metrics and a robust balance sheet. The company’s multi-pronged growth strategy, including acquisitions and a substantial development pipeline, supports a confident outlook with reaffirmed distribution guidance.

Touch Ventures Limited reported a substantial $24.9 million net loss for 2024, driven by impairments in legacy investments, while strategically pivoting with new stakes in Tixel and Reshop and welcoming Gannet Capital as a major shareholder.

Imugene’s Phase 1b trial of azer-cel, an off-the-shelf CD19 CAR T therapy, reports a 57% complete response rate in heavily pretreated diffuse large B-cell lymphoma patients, signaling a promising new option in a challenging cancer landscape.

Infomedia Ltd has agreed to acquire a 50% stake in European AI startup Intellegam GmbH for €6.1 million, marking a strategic leap to integrate cutting-edge generative AI into its automotive data solutions. The deal sets a clear path to full ownership within five years, underpinning Infomedia’s innovation-driven growth agenda.

AMP reported a robust FY24 with underlying NPAT rising 15.1% to $236 million, driven by disciplined cost management and strong cash flows. The company declared a final dividend of 1.0 cents per share and is set to launch a new digital bank in February 2025, signaling strategic growth in wealth and banking sectors.

AMP Limited’s 2024 results reveal a 43% drop in statutory net profit to $150 million, offset by a 15.1% rise in underlying profit to $236 million, alongside the completion of its Advice business sale and the launch of a new digital bank.

AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.

Civmec Limited reports solid first-half FY25 results with revenue growth and a stable dividend, while navigating margin pressures and advancing strategic projects.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

Cochlear Limited has reported a robust half-year performance with a 7% increase in underlying net profit and an 8% rise in interim dividends, driven by strong sales in cochlear and acoustic implants despite a decline in services revenue.